Latest Euclidean Capital LLC Stock Portfolio
Euclidean Capital LLC Performance:
2024 Q3: 5.8%YTD: 13.15%2023: -11.55%
Performance for 2024 Q3 is 5.8%, and YTD is 13.15%, and 2023 is -11.55%.
About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $906.8 Millions as of 30 Sep, 2024.
The top stock holdings of Euclidean Capital LLC are SPY, AMPS, VEU. The fund has invested 76.1% of it's portfolio in SPDR S&P 500 ETF TR and 15.7% of portfolio in ISHARES TR.
Euclidean Capital LLC opened new stock positions in VANGUARD INTL EQUITY INDEX F (VEU). The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY).
The top stock holdings of Euclidean Capital LLC are SPY, AMPS, VEU. The fund has invested 76.1% of it's portfolio in SPDR S&P 500 ETF TR and 15.7% of portfolio in ISHARES TR.
Euclidean Capital LLC opened new stock positions in VANGUARD INTL EQUITY INDEX F (VEU). The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY).
Euclidean Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Euclidean Capital LLC made a return of 5.8% in the last quarter. In trailing 12 months, it's portfolio return was 20.86%.
New Buys
| Ticker | $ Bought |
|---|---|
| vanguard intl equity index f | 31,978,800 |
New stocks bought by Euclidean Capital LLC
Additions
| Ticker | % Inc. |
|---|---|
| spdr s&p 500 etf tr | 4.87 |
Additions to existing portfolio by Euclidean Capital LLC
Reductions
Sold off
Sector Distribution
Euclidean Capital LLC has about 79.6% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 79.6 |
| Utilities | 15.7 |
| Healthcare | 4.7 |
Market Cap. Distribution
Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 79.6 |
| SMALL-CAP | 17.4 |
| MICRO-CAP | 2.8 |
Stocks belong to which Index?
About 20.2% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 79.8 |
| RUSSELL 2000 | 20.2 |
Euclidean Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Euclidean Capital LLC
Euclidean Capital LLC has 12 stocks in it's portfolio. TNYA proved to be the most loss making stock for the portfolio. SPY was the most profitable stock for Euclidean Capital LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.67 | 1,307,860 | 6,094,620 | unchanged | 0.00 | ||
| AMPS | ishares tr | 15.65 | 2,425,140 | 141,944,000 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 1.62 | 1,573,760 | 14,651,700 | unchanged | 0.00 | ||
| ME | 23andme holding co | 0.40 | 512,156 | 3,585,090 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals inc | 1.12 | 989,410 | 10,141,500 | unchanged | 0.00 | ||
| PMVP | pmv pharmaceuticals inc | 0.43 | 2,627,640 | 3,915,190 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 0.15 | 657,899 | 1,322,380 | unchanged | 0.00 | ||
| SPY | spdr s&p 500 etf tr | 76.11 | 1,202,800 | 690,121,000 | added | 4.87 | ||
| SRZN | surrozen inc | 0.12 | 87,696 | 1,050,600 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.00 | 170,833 | 1,760 | unchanged | 0.00 | ||
| TNYA | tenaya therapeutics inc | 0.22 | 1,015,700 | 1,960,310 | unchanged | 0.00 | ||
| VEU | vanguard intl equity index f | 3.53 | 507,600 | 31,978,800 | new | |||